News from enteris biopharma, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 19, 2016, 08:10 ET Enteris BioPharma Enhances Executive Leadership Team to Target Strategic Growth Opportunities

 Enteris BioPharma, Inc., an industry leader in oral peptide and small molecule delivery, announced today the appointment of Joel Tune as Chief...


Oct 19, 2015, 08:40 ET Enteris BioPharma's Formulation Technology Enables Oral Delivery of Tarsa Therapeutics' TBRIA™ - the First Oral Calcitonin for the Treatment of Postmenopausal Osteoporosis

Enteris BioPharma, Inc., an industry leader in oral peptide delivery, congratulates Tarsa Therapeutics on the submission of a New Drug Application...


Aug 20, 2015, 10:24 ET Enteris BioPharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' CR845 Peptide in Phase 2 Trial in Osteoarthritis

Enteris BioPharma, Inc., an industry leader in oral peptide delivery, congratulates Cara Therapeutics (Nasdaq: CARA) on the dosing of the...


Jul 14, 2015, 12:51 ET Enteris BioPharma Oral Formulation Progresses Into Phase 2 Study With Cara Therapeutics' CR845

Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that it has entered into a new agreement for...


Feb 10, 2015, 07:10 ET Enteris BioPharma Launches Contract Manufacturing within 32,000 Square Foot, FDA inspected and cGMP Compliant Facility

 Enteris BioPharma, Inc., an industry leader in oral peptide delivery, announced today the launch of contract manufacturing located within its...


Dec 09, 2014, 08:10 ET Enteris BioPharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' CR845 Peptide for Acute and Chronic Pain in Phase 1a / 1b Trial

 Enteris BioPharma, Inc., an industry leader in oral peptide delivery, congratulates Cara Therapeutics (Nasdaq: CARA) on the successful...


Jun 20, 2014, 08:10 ET Enteris BioPharma Oral Peptide Delivery Technology Enables Key Clinical Milestone for Acute and Chronic Pain Drug

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that its development partner, Cara...


Jan 09, 2014, 10:03 ET Enteris BioPharma to Present at Biotech Showcase™ 2014

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that Timothy J. Saxon, Vice President of...


Dec 03, 2013, 08:33 ET Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs

Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the appointment of Steven J. Brickner, Ph.D.,...


Sep 30, 2013, 10:40 ET Enteris BioPharma and Nordic BioScience's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, and KeyBioScience, a wholly-owned subsidiary of Nordic...


Aug 20, 2013, 08:33 ET Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand "Peptelligence™ Partnering" Program

Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the appointment of Timothy J. Saxon as Vice...


Aug 05, 2013, 08:01 ET Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics

 Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the official launch of its business,...